Chronic Lymphocytic Leukemia Clinical Trial

Clinical Trial Finder Chronic Lymphocytic Leukemia Trials

Extension Study of Idelalisib in Participants With Chronic Lymphocytic Leukemia (CLL) Who Participated in GS-US-312-0116 (NCT01539512)

See Locations Near You

Summary

The primary objective of this extension study (GS-US-312-0117) that is a companion study to Study GS-US-312-0116 (NCT01539512), is to evaluate the effect of idelalisib on the onset, magnitude, and duration of tumor control. Randomization was done in study GS-US-312-0116, and carried forward to study GS-US-312-117.

View Eligibility Criteria

Eligibility Criteria

Key Inclusion Criteria:

Individuals in the primary Phase 3 study (Study GS-US-312-0116) who are compliant
Tolerating primary study therapy

Note: Other protocol defined Inclusion/Exclusion criteria may apply.

Study is for people with:

Chronic Lymphocytic Leukemia

Phase:

Phase 3

Estimated Enrollment:

161

Study ID:

NCT01539291

Recruitment Status:

Terminated

Sponsor:

Gilead Sciences

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 44 Locations for this study

See Locations Near You

Clearview Cancer Institute
Huntsville Alabama, 35805, United States
Arizona Oncology Associates
Tucson Arizona, 85704, United States
University of California, San Diego - Moores Cancer Center
La Jolla California, 92093, United States
Ventura County Hematology Oncology Specialists
Oxnard California, 93030, United States
UCLA
Santa Monica California, 90404, United States
Stanford Cancer Center
Stanford California, 94305, United States
Rocky Mountain Blood and Marrow Transplant Program
Denver Colorado, 80218, United States
Rocky Mountain Cancer Center
Denver Colorado, 80218, United States
Georgetown University Medical Center Lombardi Cancer Center
Washington District of Columbia, 20007, United States
Collaborative Research Group
Boynton Beach Florida, 33435, United States
Florida Cancer Specialists
Fort Myers Florida, 33916, United States
Florida Cancer Specialists
Saint Petersburg Florida, 33705, United States
Northwestern University
Chicago Illinois, 60611, United States
Hackensack University Medical Center
Hackensack New Jersey, 07601, United States
Long Island Jewish Medical Center
New Hyde Park New York, 11042, United States
Weill Cornell Medical College
New York New York, 10021, United States
Columbia University Medical Center
New York New York, 10032, United States
Memorial Sloan Kettering Cancer Center
New York New York, 10065, United States
Willamette Valley Cancer Center
Springfield Oregon, 97477, United States
Northwest Cancer Specialists, PC
Tualatin Oregon, 97062, United States
Cancer Centers of the Carolinas
Greenville South Carolina, 29605, United States
Sarah Cannon Research Institute
Nashville Tennessee, 37203, United States
Texas Oncology, P.A.
Fort Worth Texas, 76104, United States
M.D. Anderson Cancer Center
Houston Texas, 77030, United States
Cancer Care Network of South Texas
San Antonio Texas, 78217, United States
Virginia Cancer Specialists, PC
Fairfax Virginia, 22031, United States
Oncology and Hematology Associates of Southwest Virginia, Inc.
Roanoke Virginia, 24014, United States
Seattle Cancer Care Alliance
Seattle Washington, 98109, United States
Yakima Valley Memorial Hospital/North Star Lodge
Yakima Washington, 98902, United States
Medical College of Wisconsin
Milwaukee Wisconsin, 53226, United States
Centre Hospitalier Lyon Sud
Pierre Benite , 69495, France
Centre Henri Becquerel
Rouen , 76038, France
Hämatologische und Internistische Gemeinschaftspraxis Dres. Eckart / Häcker
Erlangen , 91052, Germany
Universitätsklinikum Köln
Köln , 50937, Germany
Ospedale San Raffaele S.r.l.
Milano , 20132, Italy
Azienda Ospedaliera Città della Salute e della Scienza di Torino
Torino , 10126, Italy
Royal Bournemouth Hospital
Bournemouth , BH7 7, United Kingdom
Addenbrooke's Hospital
Cambridge , CB2 0, United Kingdom
Dorset County Hospital
Dorchester , DT1 2, United Kingdom
Northwick Park Hospital
Harrow , HA1 3, United Kingdom
St James's University Hospital
Leeds , LS9 7, United Kingdom
Royal Liverpool University Hospital
Liverpool , L7 8X, United Kingdom
Hammersmith Hospital
London , W12 0, United Kingdom
Princess Royal University Hospital
Orpington , BR6 8, United Kingdom
Southampton General Hospital
Southampton , SO16 , United Kingdom
Load More

How clear is this clinincal trial information?

Study is for people with:

Chronic Lymphocytic Leukemia

Phase:

Phase 3

Estimated Enrollment:

161

Study ID:

NCT01539291

Recruitment Status:

Terminated

Sponsor:


Gilead Sciences

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
Clinical Trials Using CAR-T Cells Are Extremely Promising
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider